

* Hikma agrees with Boehringer on lower price for Roxane * Cash component of initially $1.18 bln cut by $535 mln * Roxane's 2016 sales now seen below ...


(ShareCast News) - Hikma Pharmaceutical's takeover of Roxane Laboratories took on a new shape on Wednesday, with the cash consideration being almost h...